ESG & Sustainable Investing

Last year the Fortune 500 had a record 41 women CEOs. Yet US women earned just $83 for each $100 by men on average, reflecting the corporate ladder’s ‘broken rungs.’ This blog looks at female led company profiles, workplace headwinds for women, and ways to improve the flow of meritocracy.

With environmental and social factors rightly growing in prominence in the field of ESG, TwentyFour portfolio manager Chris Bowie explains why governance should still matter to bond investors

The nature we depend on is bleeding as natural habitat is cleared to support population growth, consumption and waste. Nature, society and the health of our portfolios are interlinked. This blog ties biodiversity hot spots to the impact of individual companies. Get ahead of risk and regulation.

TwentyFour Asset Management’s portfolio management team offer bond issuers three tips on improving their ESG data disclosure, and explain why companies shouldn’t attempt to fool them.

Graeme Anderson shares five lessons from sustainable bond investing, including how E and S are catching up to G and why Coca-Cola scores higher than Tesla.

In recent months and years we have seen remarkable growth in the number of ESG-focused or sustainable investment strategies being offered by asset managers, a trend that first emerged in the equity market but is now making itself felt in the world of fixed income.

To many, investing in sustainability is commonsense. To some, it is more of a bureaucratic waste of time with onerous new regulations. To us, it is clear that ESG is an integral part of evaluating business quality because, simply put, sustainability has a material impact on long-term value.

We can model all kinds of credit risk as long as there is enough protection in the structure for investors to get comfortable with a degree of residual value risk.

As companies and individuals adopt sustainable practices, we believe the potential exists for inflationary consequences.

It is hard to draw any immediate conclusion from this transaction other than Repsol's notable persistence to obtain sustainable financing.

In both instances, the good intentions of the regulator and the authorities are clear… But at the same time both changes have the potential to cause an increasingly undesired side effect.

10 million lab animals undergo tests with severe pain each year. Over time, companies have aligned with customers. The near-term exit for lab animals relies on regulators. A 2021 breakthrough in China shows progress. But the underlying driver is remarkable advances in technology. Management views and outlook in this blog.